Wednesday, 28 February 2024

Business News

Xenetic Biosciences Shares Insights on Oncology Platform – TipRanks Financial Blog

Penumbra upgraded to Buy from Neutral at Citi

Xenetic Biosciences (XBIO) has released an update.

Xenetic Biosciences, Inc. recently showcased a virtual investor event video featuring their Chief Scientific Officer, Dr. Curis Lockshin, who discussed exciting preclinical data from their DNase I oncology platform. Interested parties can easily access this insightful video via the provided link to gain a deeper understanding of the company’s innovative approach to cancer treatment. This resource offers a valuable glimpse into Xenetic’s cutting-edge research and development efforts in the field of oncology.

For further insights into XBIO stock, check out TipRanks’ Stock Analysis page.

Click Here to Read the Full Original Article at TipRanks Financial Blog…